Literature DB >> 26966181

Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis.

Hongling Zhao1, Hongbo Wang1, Frederick Bauzon1, Zhonglei Lu1, Hao Fu1, Jinhua Cui1, Liang Zhu2.   

Abstract

Tumor suppressor pRb represses Skp2, a substrate-recruiting subunit of the SCF(Skp2) ubiquitin ligase. Rb1(+/-) mice incur "two-hit" pituitary tumorigenesis; Skp2(-/-);Rb1(+/-) mice do not. Rb1(-/-) embryos die on embryonic day (E) 14.5-15.5. Here, we report that Skp2(-/-);Rb1(-/-) embryos died on E11.5, establishing an organismal level synthetic lethal relationship between Rb1 and Skp2 On E10.5, Rb1(-/-) placentas showed similarly active proliferation and similarly inactive apoptosis as WT placenta, whereas Rb1(-/-) embryos showed ectopic proliferation without increased apoptosis in the brain. Combining Skp2(-/-) did not reduce proliferation or increase apoptosis in the placentas but induced extensive apoptosis in the brain. We conditionally deleted Rb1 in neuronal lineage with Nes-Cre and reproduced the brain apoptosis in E13.5 Nes-Cre;Rb1(lox/lox);Skp2(-/-) embryos, demonstrating their synthetic lethal relationship at a cell autonomous level. Nes-Cre-mediated Rb1 deletion increased expression of proliferative E2F target genes in the brains of Skp2(+/+) embryos; the increases rose higher with activation of expression of apoptotic E2F target genes in Skp2(-/-) embryos. The brain apoptosis was independent of p53 but coincident with proliferation. The highly activated expression of proliferative and apoptotic E2F target genes subsided with gradually reduced roles of Skp2 in preventing p27 protein accumulation in the brain in late gestation, allowing the embryos to reach full term with normally sized brains. These findings establish that Rb1 and Skp2 deletions are synthetic lethal and suggest how this lethal relationship might be circumvented, which could help design better therapies for pRb-deficient cancer.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell death; cell proliferation; embryo; proliferating cell nuclear antigen (PCNA); tumor suppressor gene

Mesh:

Substances:

Year:  2016        PMID: 26966181      PMCID: PMC4858970          DOI: 10.1074/jbc.M116.718049

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

2.  Extra-embryonic function of Rb is essential for embryonic development and viability.

Authors:  Lizhao Wu; Alain de Bruin; Harold I Saavedra; Maja Starovic; Anthony Trimboli; Ying Yang; Jana Opavska; Pamela Wilson; John C Thompson; Michael C Ostrowski; Thomas J Rosol; Laura A Woollett; Michael Weinstein; James C Cross; Michael L Robinson; Gustavo Leone
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

3.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.

Authors:  Peng Ji; Hong Jiang; Katya Rekhtman; Joanna Bloom; Marina Ichetovkin; Michele Pagano; Liang Zhu
Journal:  Mol Cell       Date:  2004-10-08       Impact factor: 17.970

5.  E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.

Authors:  U Ziebold; T Reza; A Caron; J A Lees
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

6.  F-box protein Skp2: a novel transcriptional target of E2F.

Authors:  L Zhang; C Wang
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

7.  Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

Authors:  S Marino; M Vooijs; H van Der Gulden; J Jonkers; A Berns
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

8.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.

Authors:  A Lasorella; M Noseda; M Beyna; Y Yokota; A Iavarone
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

9.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.

Authors:  Julien Sage; Abigail L Miller; Pedro A Pérez-Mancera; Julianne M Wysocki; Tyler Jacks
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

10.  E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.

Authors:  Ulrike Ziebold; Eunice Y Lee; Roderick T Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more
  3 in total

Review 1.  Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.

Authors:  Pranav Gupta; Hongling Zhao; Bang Hoang; Edward L Schwartz
Journal:  Br J Cancer       Date:  2022-06-25       Impact factor: 9.075

2.  Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung Cancer.

Authors:  Hongling Zhao; Niloy J Iqbal; Vineeth Sukrithan; Cari Nicholas; Yingjiao Xue; Cindy Yu; Joseph Locker; Juntao Zou; Edward L Schwartz; Liang Zhu
Journal:  Cancer Res       Date:  2020-04-07       Impact factor: 12.701

3.  Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival.

Authors:  Matthew G Oser; Raquel Fonseca; Abhishek A Chakraborty; Rachel Brough; Alexander Spektor; Rebecca B Jennings; Abdallah Flaifel; Jesse S Novak; Aditi Gulati; Elizabeth Buss; Scott T Younger; Samuel K McBrayer; Glenn S Cowley; Dennis M Bonal; Quang-De Nguyen; Laura Brulle-Soumare; Paula Taylor; Stefano Cairo; Colm J Ryan; Elizabeth J Pease; Kim Maratea; Jon Travers; David E Root; Sabina Signoretti; David Pellman; Susan Ashton; Christopher J Lord; Simon T Barry; William G Kaelin
Journal:  Cancer Discov       Date:  2018-10-29       Impact factor: 39.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.